Print

Purpose

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 125 Years
Eligible Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion Criteria

  • Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter - Patients under 18 years of age - Patients not admitted as inpatients. - Patients on comfort care only - Patients discharged to hospice.

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Other

Recruiting Locations

Amy Bennett
Dallas, Texas 75231
Contact:
Amy Bennett, JD
214-706-4881
amy.bennett@heart.org

More Details

Status
Recruiting
Sponsor
American Heart Association

Study Contact

Amy Bennett, JD
214-706-2237
amy.bennett@heart.org

Detailed Description

Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement. Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation: 1. ACEI/ARB at discharge for LVSD 2. Assessment of thromboembolic risk factors 3. Beta Blocker at discharge 4. Discharged on FDA-approved anticoagulation therapy 5. PT/INR planned follow-up 6. Statin at discharge in AF patients with CAD, CVA/TIA or PVD. Quality measures tracked through Get With The Guidelines-Atrial Fibrillation: 1. Aldosterone antagonist at discharge 2. Atrial fibrillation patient education 3. Anticoagulation therapy education 4. CHA2DS2-VASC reported 5. Discharge heart rate <110bpm 6. Smoking cessation 7. Warfarin at discharge for valvular atrial fibrillation Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloada ble/ucm_451183.pdf

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.